The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Helio S. Sader

JMI Laboratories

North Liberty

USA

[email]@jmilabs.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • JMI Laboratories, North Liberty, USA. 2003 - 2013
  • Address correspondence to Helio S. Sader. 2012
  • JMI Laboratories, 345 Beaver Kreek Centre, Suite A, North Liberty. 2009 - 2011
  • Laboratorio Alerta e Laboratorio Especial de Microbiologia Clínica, Disciplina de Doenças Infecciosas e Parasitárias, Universidade Federal de São Paulo, São Paulo, Brazil. 2005
  • Special Laboratory of Clinical Microbiology, Division of Infectious Diseases, Federal University of São Paulo, São Paulo, Brazil. 2004

References

  1. Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010-2011. Sader, H.S., Flamm, R.K., Jones, R.N. Antimicrob. Agents Chemother. (2013) [Pubmed]
  2. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program. Sader, H.S., Flamm, R.K., Farrell, D.J., Jones, R.N. Clin. Infect. Dis. (2012) [Pubmed]
  3. Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections. Sader, H.S., Biedenbach, D.J., Paukner, S., Ivezic-Schoenfeld, Z., Jones, R.N. Antimicrob. Agents Chemother. (2012) [Pubmed]
  4. Tigecycline activity tested against multidrug-resistant Enterobacteriaceae and Acinetobacter spp. isolated in US medical centers (2005-2009). Sader, H.S., Farrell, D.J., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2011) [Pubmed]
  5. Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes. Sader, H.S., Rhomberg, P.R., Farrell, D.J., Jones, R.N. Antimicrob. Agents Chemother. (2011) [Pubmed]
  6. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008). Sader, H.S., Becker, H.K., Moet, G.J., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2010) [Pubmed]
  7. Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres. Sader, H.S., Farrell, D.J., Jones, R.N. Int. J. Antimicrob. Agents (2010) [Pubmed]
  8. Antimicrobial resistance among Gram-positive bacteria isolated in Latin American hospitals. Sader, H.S., Moet, G.J., Jones, R.N. J. Chemother (2009) [Pubmed]
  9. Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates. Sader, H.S., Fritsche, T.R., Jones, R.N. Antimicrob. Agents Chemother. (2009) [Pubmed]
  10. Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. Sader, H.S., Fey, P.D., Limaye, A.P., Madinger, N., Fish, D.N., Pankey, G., Rahal, J., Rybak, M.J., Snydman, D.R., Steed, L.L., Waites, K., Jones, R.N. Antimicrob. Agents Chemother. (2009) [Pubmed]
  11. Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus. Sader, H.S., Rhomberg, P.R., Jones, R.N. Antimicrob. Agents Chemother. (2009) [Pubmed]
  12. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. Sader, H.S., Jones, R.N., Rossi, K.L., Rybak, M.J. J. Antimicrob. Chemother. (2009) [Pubmed]
  13. Update on the in vitro activity of daptomycin tested against 17,193 Gram-positive bacteria isolated from European medical centers (2005-2007). Sader, H.S., Moet, G., Jones, R.N. J. Chemother (2009) [Pubmed]
  14. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Sader, H.S., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2009) [Pubmed]
  15. Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients. Sader, H.S., Fritsche, T.R., Jones, R.N. Int. J. Infect. Dis. (2009) [Pubmed]
  16. Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers. Sader, H.S., Watters, A.A., Fritsche, T.R., Jones, R.N. J. Chemother (2008) [Pubmed]
  17. Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus. Sader, H.S., Fritsche, T.R., Jones, R.N. Antimicrob. Agents Chemother. (2008) [Pubmed]
  18. Frequency of occurrence and daptomycin susceptibility rates of Gram-positive organisms causing bloodstream infections in cancer patients. Sader, H.S., Fritsche, T.R., Jones, R.N. J. Chemother (2008) [Pubmed]
  19. Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent. Sader, H.S., Koeth, L.M., Poupard, J.A., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2008) [Pubmed]
  20. Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype. Sader, H.S., Hsiung, A., Fritsche, T.R., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2007) [Pubmed]
  21. Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae. Sader, H.S., Ferraro, M.J., Reller, L.B., Schreckenberger, P.C., Swenson, J.M., Jones, R.N. J. Clin. Microbiol. (2007) [Pubmed]
  22. In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004). Sader, H.S., Fritsche, T.R., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2007) [Pubmed]
  23. Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections. Sader, H.S., Mallick, R., Kuznik, A., Fritsche, T.R., Jones, R.N. Int. J. Antimicrob. Agents (2007) [Pubmed]
  24. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005). Sader, H.S., Watters, A.A., Fritsche, T.R., Jones, R.N. BMC Infect. Dis. (2007) [Pubmed]
  25. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. Sader, H.S., Jacobs, M.R., Fritsche, T.R. Diagn. Microbiol. Infect. Dis. (2007) [Pubmed]
  26. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections. Sader, H.S., Jones, R.N. Expert. Rev. Anti. Infect. Ther (2007) [Pubmed]
  27. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents. Sader, H.S., Fritsche, T.R., Jones, R.N. J. Clin. Microbiol. (2006) [Pubmed]
  28. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Sader, H.S., Fritsche, T.R., Jones, R.N. Antimicrob. Agents Chemother. (2006) [Pubmed]
  29. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Sader, H.S., Streit, J.M., Fritsche, T.R., Jones, R.N. Clin. Microbiol. Infect. (2006) [Pubmed]
  30. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Sader, H.S., Castanheira, M., Mendes, R.E., Toleman, M., Walsh, T.R., Jones, R.N. Int. J. Antimicrob. Agents (2005) [Pubmed]
  31. Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections. Sader, H.S., Biedenbach, D.J., Streit, J.M., Jones, R.N. Int. J. Antimicrob. Agents (2005) [Pubmed]
  32. IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital. Sader, H.S., Reis, A.O., Silbert, S., Gales, A.C. Clin. Microbiol. Infect. (2005) [Pubmed]
  33. Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli. Sader, H.S., Jones, R.N. Int. J. Antimicrob. Agents (2005) [Pubmed]
  34. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp. Sader, H.S., Jones, R.N. Int. J. Antimicrob. Agents (2005) [Pubmed]
  35. Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains. Sader, H.S., Fritsche, T.R., Kaniga, K., Ge, Y., Jones, R.N. Antimicrob. Agents Chemother. (2005) [Pubmed]
  36. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003). Sader, H.S., Fritsche, T.R., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2005) [Pubmed]
  37. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003). Sader, H.S., Fritsche, T.R., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2005) [Pubmed]
  38. Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003. Sader, H.S., Fritsche, T.R., Streit, J.M., Jones, R.N. J. Chemother (2005) [Pubmed]
  39. In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii. Sader, H.S., Rhomberg, P.R., Jones, R.N. J. Chemother (2005) [Pubmed]
  40. Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity. Sader, H.S., Fedler, K.A., Rennie, R.P., Stevens, S., Jones, R.N. Antimicrob. Agents Chemother. (2004) [Pubmed]
  41. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001. Sader, H.S., Jones, R.N., Gales, A.C., Silva, J.B., Pignatari, A.C. Braz. J. Infect. Dis (2004) [Pubmed]
  42. Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates. Sader, H.S., Streit, J.M., Fritsche, T.R., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2004) [Pubmed]
  43. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide. Sader, H.S., Streit, J.M., Fritsche, T.R., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2004) [Pubmed]
  44. Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001). Sader, H.S., Biedenbach, D.J., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2003) [Pubmed]
  45. Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002). Sader, H.S., Fritsche, T.R., Mutnick, A.H., Jones, R.N. Diagn. Microbiol. Infect. Dis. (2003) [Pubmed]
 
WikiGenes - Universities